Redwoods Acquisition Corp. (RWOD)
After hours:
| Previous close | 6.18 |
| Open | 6.99 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 6.48 - 7.10 |
| 52-week range | 4.98 - 13.10 |
| Volume | |
| Avg. volume | 117,227 |
| Market cap | 36.105M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 49.93 |
| EPS (TTM) | 0.14 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
BenzingaWhy SPAC Redwoods Acquisition Shares Are Skyrocketing Friday?
Redwoods Acquisition Corp. (NASDAQ:RWOD) shares traded higher on Friday after the company announced that shareholders had approved its merger agreement with Anew Medical. Following the consummation of the transactions, Redwoods will change its name to Anew Medical, the company said in an exchange filing (April 18). On May 30, 2023, Redwoods Acquisition entered into a business combination agreement with Anew Medical Sub, Inc. The transaction values the combined company at a pro forma enterprise v
Simply Wall St.Redwoods Acquisition Corp. (NASDAQ:RWOD) surges 16%; retail investors who own 42% shares profited along with insiders
Key Insights Significant control over Redwoods Acquisition by retail investors implies that the general public has more...
PR NewswireANEW MEDICAL ANNOUNCES KEY PATENT ISSUED IN CHINA TO PROTECT KLOTHO PROTEIN AND GENE DELIVERY SYSTEMS
ANEW MEDICAL, INC. ("ANEW" or "the Company") (OTCPK: LEAS) a US-based biotechnology company ("ANEW") focused on developing cell and gene- based treatments to affect aging and age-related diseases, announced that is has been granted and issued a patent in China, number CN 117126829 A for the use of ANEW's Klotho protein and Klotho gene delivery and expression systems in the treatment of cognition, memory and neurodegenerative diseases. This intellectual property was licensed by ANEW from UNIVERSI
